While the basic principles of personalized medicine and pharmacogenomics has been covered by numerous texts, there are none to date that focuses on the specific tests themselves that are in current clinical practice and those that are being proposed for implementation in the near future. Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory focuses almost entirely on the specifics of each test that is needed to implement these tests into a clinical laboratory. This volume presents the first compilation of the tests currently in routine clinical use. The chapter authors of this unique and invaluable title comprise a range of renowned authorities and investigators who have conducted the essential clinical trials necessary to justify pharmacogenomic testing today. The book is divided into four parts: Basic Concepts, Specific Pharmacogenomic Targets, Drugs that Cause Delayed Hypersensitivity, and Miscellaneous Drugs. Each author provides a pharmacologic background on the target drug, the need for pharmacogenomic testing, and how results can be translated into clinical decisions. Where appropriate, case studies are given to illustrate typical clinical scenarios. An extensive bibliography is provided so that the reader can refer to the original studies. This well-designed resource will appeal to clinical laboratory directors who are contemplating or assigned the task of establishing a pharmacogenomics laboratory and a wide range of clinicians who must interpret results of testing. Focused and immensely useful, Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory is a timely and outstanding contribution to the literature and will be instrumental in defining this rapidly growing field.

This volume provides a concise yet comprehensive overview of minimal residual disease (MRD) testing. The text reviews the history of MRD testing, MRD testing for acute lymphoblastic leukemia/lymphoma, molecular diagnostics for MRD analysis in hematopoietic malignancies, the use of "difference from normal" flow cytometry in monitoring AML response, ML-DS for measurable residual disease detection, and advancements in next generation sequencing for detecting MRD. Written by experts in the field, Minimal Residual Disease Testing: Current Innovations and Future Directions is a valuable resource for hematologists, oncologists, pathologists, and radiologists on the variety of technologies available to detect MRD and how best to integrate these platforms into clinical practice.

Growing up in a small upper Midwestern town in the late 1930s, young Tommy MacAllister is scarcely aware of the Depression, much less the rumblings of war in Europe. For his parents and their set, life seems to revolve around dinners and dancing at the country club, tennis dates and rounds of golf, holiday parties, summers on the Island, and sparkling occasions full of people and drinks and food and laughter. But curious as he is and impatient to grow up, Tommy will soon come to glimpse the darkness that lies beneath so much genteel complacency: hidden histories and embarrassing poor relations; the subtle (and not so subtle) slighting of the “help”; the mockery of President Roosevelt; and “the commandment they talked least about in Sunday school,” adultery. In Testing the Current William McPherson subtly sets off his wide-eyed protagonist’s perspective with mature reflection and wry humor and surrounds him with a cast of vibrant characters, creating a scrupulously observed portrait of a place and time that will shimmer in readers’ minds long after the final page is turned.

This book elaborates on the topics covered by top experts in the field of drug testing at an international symposium held in March, 1990. The book is an excellent reference for all professionals involved in the set up, performance and interpretation of results for drug testing programs using biological fluids (especially urine). U.S. and European perspectives are presented in relation to workplace testing. Organizational aspects for reliability of drug testing include topics ranging from sample collection, chain of custody, and laboratory strategies to legal and regulatory aspects. Critical reviews of analytical methodology involve descriptions and critical issues for the major presumptive and confirmatory techniques, including immunological and gas chromatographic-mass spectrometric methodologies. The book's interpretation of results takes into account the metabolic, pharmacokinetic, pharmacodynamic and clinical aspects. The final chapters of the book include topics addressing aspects for potential international harmonization.